Back to today’s briefing

Story perspectives

New Peptide Revolutionizes Gene Delivery with 48% Transfer Rate

5/2/2025

28 4

Summary

Story summary

A groundbreaking chimeric peptide, CTATMPG2H, has emerged as a promising alternative to viral carriers for gene delivery. Achieving an impressive 48% gene transfer rate in dendritic cells with minimal toxicity, this innovation paves the way for safer gene therapy solutions and sets the stage for future clinical applications and in vivo studies.

1 of 1

Story summary

A groundbreaking chimeric peptide, CTATMPG2H, has emerged as a promising alternative to viral carriers for gene delivery. Achieving an impressive 48% gene transfer rate in dendritic cells with minimal toxicity, this innovation paves the way for safer gene therapy solutions and sets the stage for future clinical applications and in vivo studies.